Parkinson’s Disease (PD) is characterized by a spectrum of symptoms, including movement disabilities and non-motor neuropsychiatric, sleep, sensory, and autonomic complications. Fluctuations of symptoms in PD create an additional burden for patients and, due to difficulties in their recognition and tracking, impediments to optimal management of the disease. This case report details the daily monitoring and graphing of motor and non-motor symptoms in a 72-year-old Parkinson’s disease patient. Following a reduction in the patient’s carbidopa/levodopa dosage, a caregiver used a custom observational scale to chart symptom fluctuations over three weeks. The study finds that the medication adjustment correlated with an attenuation of symptom fluctuations, suggesting this caregiver-led method may be a useful tool for tracking treatment effects in PD management.
References
[1]
Jankovic, J. (2008) Parkinson’s Disease: Clinical Features and Diagnosis. JournalofNeurology, Neurosurgery&Psychiatry, 79, 368-376. https://doi.org/10.1136/jnnp.2007.131045
[2]
Magrinelli, F., Picelli, A., Tocco, P., Federico, A., Roncari, L., Smania, N., et al. (2016) Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation. Parkinson’sDisease, 2016, Article ID: 9832839. https://doi.org/10.1155/2016/9832839
[3]
Todorova, A., Jenner, P. and Ray Chaudhuri, K. (2014) Non-Motor Parkinson’s: Integral to Motor Parkinson’s, Yet Often Neglected. PracticalNeurology, 14, 310-322. https://doi.org/10.1136/practneurol-2013-000741
[4]
Chaudhuri, K.R., Healy, D.G. and Schapira, A.H. (2006) Non-Motor Symptoms of Parkinson’s Disease: Diagnosis and Management. TheLancetNeurology, 5, 235-245. https://doi.org/10.1016/s1474-4422(06)70373-8
[5]
Chou, K.L., Stacy, M., Simuni, T., Miyasaki, J., Oertel, W.H., Sethi, K., et al. (2018) The Spectrum of “Off” in Parkinson’s Disease: What Have We Learned over 40 Years? Parkinsonism&RelatedDisorders, 51, 9-16. https://doi.org/10.1016/j.parkreldis.2018.02.001
[6]
Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez-Martin, P., et al. (2008) Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results. MovementDisorders, 23, 2129-2170. https://doi.org/10.1002/mds.22340
[7]
Chaudhuri, K.R., Martinez-Martin, P., Schapira, A.H.V., Stocchi, F., Sethi, K., Odin, P., et al. (2006) International Multicenter Pilot Study of the First Comprehensive Self-completed Nonmotor Symptoms Questionnaire for Parkinson’s Disease: The Nmsquest Study. MovementDisorders, 21, 916-923. https://doi.org/10.1002/mds.20844
[8]
Borzì, L., Varrecchia, M., Olmo, G., Artusi, C.A., Fabbri, M., Rizzone, M.G., et al. (2019) Home Monitoring of Motor Fluctuations in Parkinson’s Disease Patients. JournalofReliableIntelligentEnvironments, 5, 145-162. https://doi.org/10.1007/s40860-019-00086-x
[9]
Santiago, A., Langston, J.W., Gandhy, R., Dhall, R., Brillman, S., Rees, L., et al. (2019) Qualitative Evaluation of the Personal Kinetigraphtm Movement Recording System in a Parkinson’s Clinic. JournalofParkinson’sDisease, 9, 207-219. https://doi.org/10.3233/jpd-181373
[10]
Richard, I.H., Justus, A.W. and Kurlan, R. (2001) Relationship between Mood and Motor Fluctuations in Parkinson’s Disease. TheJournalofNeuropsychiatryandClinicalNeurosciences, 13, 35-41. https://doi.org/10.1176/jnp.13.1.35
[11]
Mark, M.H. and Sage, J.I. (1989) Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson’s Disease. Annals of Clinical & Laboratory Science, 19, 101-106.
[12]
Del Tredici, K. and Braak, H. (2000-2013) Idiopathic Parkinson’s Disease: Staging an α-Synucleinopathy with a Predictable Pathoanatomy. In: MadameCurieBioscienceDatabase, Landes Bioscience, 1-54. https://www.ncbi.nlm.nih.gov/books/NBK6077/
Storch, A., Schneider, C.B., Wolz, M., Stürwald, Y., Nebe, A., Odin, P., et al. (2013) Nonmotor Fluctuations in Parkinson Disease: Severity and Correlation with Motor Complications. Neurology, 80, 800-809. https://doi.org/10.1212/wnl.0b013e318285c0ed
